Armbruster Capital Management’s Abbott ABT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,437
Closed -$202K 125
2021
Q4
$202K Buy
+1,437
New +$184K 0.05% 121
2018
Q2
Sell
-600
Closed -$36K 71
2018
Q1
$36K Sell
600
-74
-11% -$4.46K 0.02% 145
2017
Q4
$38K Hold
674
0.02% 141
2017
Q3
$36K Sell
674
-229
-25% -$11.5K 0.02% 141
2017
Q2
$44K Buy
903
+3
+0.3% +$136 0.02% 132
2017
Q1
$40K Sell
900
-200
-18% -$8.65K 0.02% 139
2016
Q4
$42K Hold
1,100
0.02% 133
2016
Q3
$47K Sell
1,100
-88
-7% -$3.77K 0.03% 126
2016
Q2
$47K Buy
1,188
+100
+9% +$3.98K 0.03% 130
2016
Q1
$46K Hold
1,088
0.03% 133
2015
Q4
$49K Buy
+1,088
New +$48K 0.04% 128

Other funds holding ABT

Armbruster Capital Management's ABT Position: Q1 2022 in Review

Armbruster Capital Management sold out of Abbott (ABT) in Q1 2022, closing a stake of 1,437 shares — an estimated $202K sold.

Armbruster Capital Management first reported a position in ABT in Q4 2015 and held it in 11 quarters. The position peaked at $202K in Q4 2021. 2,760 funds tracked by Wall St. Rank hold ABT as of Q1 2022.

  • Armbruster Capital Management reported no remaining Abbott position as of Q1 2022 after selling out during the quarter.
  • Armbruster Capital Management sold 1,437 Abbott shares in Q1 2022, an estimated $202K.
  • Armbruster Capital Management first reported a position in Abbott in Q4 2015 and held it in 11 quarters.
  • Armbruster Capital Management's Abbott position peaked at $202K in Q4 2021.
  • 2,760 funds tracked by Wall St. Rank held Abbott as of Q1 2022.

Based on Armbruster Capital Management's 13F filing for Q1 2022, filed 5 May 2022.